Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Genenta Science S.p.A
GNTA | US
2.20
USD0.55
33.33%
GNTA | US
About Genenta Science S.p.A
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/12/2023
As of date
02/06/2026
Close
2.20
Open
1.59
High
2.58
Low
1.53
Genenta Science S.p.A. a clinical-stage biotechnology company engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is also developing Temferon for use in the treatment of other solid tumor indications locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. In addition it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan Italy.
View LessGNTA | US
Risk
269.8
Sharpe
-0.35
Luna's Score
55/100
Recommendation
Hold
Luna says (GNTA | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
344.4%1 month
269.8%3 months
176.0%6 months
144.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.52
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
-11.48
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-11.69M
MarketCap
40.08M
MarketCap(USD)
40.08M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-45.16
Short ratio
0.64
Short perc.
0.04
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.03
Range1M
2.03
Range3M
2.03
Volumes: Market Activity
Rel. volume
1.56
Price X volume
13.36M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -11.48 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.52 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 176.01 | - | Riskier |
| Debt to Equity | 0.00 | -1.23 | Expensive |
| Debt to Assets | 0.00 | 0.25 | Cheaper |
| Market Cap | 40.08M | - | Emerging |
